Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects

NCT02075073 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
109
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samsung Bioepis Co., Ltd.